ODAPH

gene
On this page

Also known as FLJ23657AI2A4

Summary

ODAPH (odontogenesis associated phosphoprotein, HGNC:26300) is a protein-coding gene on chromosome 4q21.1, encoding Odontogenesis associated phosphoprotein (Q17RF5). May promote nucleation of hydroxyapatite.

Dental enamel forms the outer cap of teeth and is the hardest substance found in vertebrates. This gene is thought to encode an extracellular matrix acidic phosphoprotein that has a function in enamel mineralization during amelogenesis. Mutations in this gene are associated with recessive hypomineralized amelogenesis imperfecta.

Source: NCBI Gene 152816 — RefSeq curated summary.

At a glance

  • Gene–disease (curated): amelogenesis imperfecta hypomaturation type 2A4 (Strong, GenCC) — +1 more curated relationship
  • GWAS associations: 2
  • Clinical variants (ClinVar): 24 total — 3 pathogenic, 4 likely-pathogenic
  • Phenotypes (HPO): 4
  • MANE Select transcript: NM_178497

Identifiers

Gene identifiers

FieldValue
HGNC IDHGNC:26300
Approved symbolODAPH
Nameodontogenesis associated phosphoprotein
Location4q21.1
Locus typegene with protein product
StatusApproved
AliasesFLJ23657, AI2A4
Ensembl geneENSG00000174792
Ensembl biotypeprotein_coding
OMIM614829
Entrez152816

Gene structure

Transcript identifiers

Ensembl transcripts: 5 — 3 protein_coding, 1 nonsense_mediated_decay, 1 protein_coding_CDS_not_defined

ENST00000311623, ENST00000435974, ENST00000511093, ENST00000514064, ENST00000616557

RefSeq mRNA: 3 — MANE Select: NM_178497 NM_001206981, NM_001257072, NM_178497

CCDS: CCDS3569, CCDS56334, CCDS75142

Canonical transcript exons

ENST00000311623 — 2 exons

ExonStartEnd
ENSE000000003447555606675556149
ENSE000017620327556411475564817

Expression profiles

Bgee: expression breadth ubiquitous, 153 present calls, max score 77.92.

FANTOM5 (CAGE): breadth broad, TPM avg 3.0045 / max 2324.3356, expressed in 215 samples.

FANTOM5 promoters (1 alternative TSS)

Promoter IDTPM avgSamples expressed
483013.0045215

Top tissues by expression

252 total, by Bgee expression score (0-100, higher = more expressed):

TissueAnatomy IDExpression scoreQuality
male germ line stem cell (sensu Vertebrata) in testisCL:0000089 ∩ UBERON:000047377.92gold quality
buccal mucosa cellCL:000233669.50silver quality
placentaUBERON:000198768.95gold quality
C1 segment of cervical spinal cordUBERON:000646963.48gold quality
gastrocnemiusUBERON:000138862.27gold quality
spinal cordUBERON:000224061.37gold quality
muscle of legUBERON:000138360.32gold quality
mucosa of stomachUBERON:000119959.61gold quality
Brodmann (1909) area 9UBERON:001354058.04gold quality
gingivaUBERON:000182857.55gold quality
ileal mucosaUBERON:000033157.47silver quality
tibialis anteriorUBERON:000138557.37silver quality
substantia nigraUBERON:000203856.83gold quality
amygdalaUBERON:000187656.56gold quality
nucleus accumbensUBERON:000188256.04gold quality
putamenUBERON:000187455.93gold quality
midbrainUBERON:000189154.87gold quality
cerebellar hemisphereUBERON:000224554.82gold quality
right uterine tubeUBERON:000130254.74gold quality
tibial nerveUBERON:000132354.54gold quality
cerebellar cortexUBERON:000212954.52gold quality
hypothalamusUBERON:000189854.48gold quality
cardiac muscle of right atriumUBERON:000337954.34gold quality
left ventricle myocardiumUBERON:000656654.23gold quality
right frontal lobeUBERON:000281054.04gold quality
caudate nucleusUBERON:000187354.01gold quality
gingival epitheliumUBERON:000194954.00silver quality
kidney epitheliumUBERON:000481953.93gold quality
right hemisphere of cerebellumUBERON:001489053.69gold quality
primordial germ cell in gonadCL:0000670 ∩ UBERON:000099153.65gold quality

Single-cell (SCXA)

Detected in 1 experiment(s), a significant marker in 0.

ExperimentMarker?Max mean expression
E-ANND-3no3.56

Regulation

Is transcription factor: no

miRNA regulators (miRDB)

115 targeting ODAPH, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):

miRNAMax scoreAvg scoremiRNA target_count
HSA-MIR-4795-3P100.0074.624024
HSA-MIR-126-5P100.0072.713180
HSA-MIR-656-3P100.0072.152788
HSA-MIR-6740-5P100.0065.64932
HSA-MIR-518D-5P100.0067.51979
HSA-MIR-518E-5P100.0067.66954
HSA-MIR-518F-5P100.0067.51979
HSA-MIR-519A-5P100.0067.66954
HSA-MIR-519B-5P100.0067.66954
HSA-MIR-519C-5P100.0067.66954
HSA-MIR-520C-5P100.0067.51979
HSA-MIR-522-5P100.0067.66954
HSA-MIR-523-5P100.0067.66954
HSA-MIR-526A-5P100.0067.51979
HSA-MIR-548N99.9871.944170
HSA-MIR-32-5P99.9875.211964
HSA-MIR-92A-3P99.9875.211960
HSA-MIR-92B-3P99.9875.251955
HSA-MIR-25-3P99.9874.601817
HSA-MIR-363-3P99.9874.721821
HSA-MIR-367-3P99.9874.831819
HSA-MIR-55999.9572.283609
HSA-MIR-548AB99.9571.313488
HSA-MIR-548A-5P99.9471.273482
HSA-MIR-548AD-5P99.9471.233502
HSA-MIR-548AE-5P99.9471.233502
HSA-MIR-548AK99.9471.243488
HSA-MIR-548AM-5P99.9471.243488
HSA-MIR-548AP-5P99.9471.143489
HSA-MIR-548AQ-5P99.9471.343426

Literature-anchored findings (GeneRIF, showing 1)

  • Autozygosity mapping and clonal sequencing of an Omani family identified mutations in the uncharacterized gene, C4orf26, as a cause of recessive hypomineralized amelogenesis imperfecta (PMID:22901946)

Cross-species orthologs

2 orthologs

OrganismSymbolGene ID
mus_musculusOdaphENSMUSG00000096035
rattus_norvegicusOdaphENSRNOG00000079983

Protein

Protein identifiers

Odontogenesis associated phosphoproteinQ17RF5 (reviewed: Q17RF5)

All UniProt accessions (3): Q17RF5, A0A087WV33, D6RFW7

UniProt curated annotations — full annotation on UniProt →

Function. May promote nucleation of hydroxyapatite.

Subcellular location. Secreted.

Tissue specificity. Highly expressed in placenta.

Disease relevance. Amelogenesis imperfecta, hypomaturation type, 2A4 (AI2A4) [MIM:614832] A defect of enamel formation. The disorder involves both primary and secondary dentitions. The teeth have a shiny agar jelly appearance and the enamel is softer than normal. Brown pigment is present in middle layers of enamel. The disease is caused by variants affecting the gene represented in this entry.

Isoforms (2)

UniProt IDNamesCanonical?
Q17RF5-11yes
Q17RF5-22

RefSeq proteins (3): NP_001193910, NP_001244001, NP_848592* (*=MANE)

Domains & families (InterPro)

IDNameType
IPR031706ODAPHFamily

Pfam: PF15848

UniProt features (6 total): sequence variant 2, signal peptide 1, chain 1, splice variant 1, sequence conflict 1

Structure

Experimental structures (PDB)

0 structures.

Predicted structure (AlphaFold)

ModelpLDDTFraction very-high
AF-Q17RF5-F161.640.05

Function

Pathways and Gene Ontology

Reactome pathways

0 pathways

MSigDB gene sets: 88 (showing top): RACCACAR_AML_Q6, GOBP_TOOTH_MINERALIZATION, GOBP_ANIMAL_ORGAN_MORPHOGENESIS, GOBP_ENAMEL_MINERALIZATION, OCT1_07, TGANTCA_AP1_C, GOBP_AMELOGENESIS, RYTTCCTG_ETS2_B, SENESE_HDAC1_TARGETS_UP, GOBP_ODONTOGENESIS_OF_DENTIN_CONTAINING_TOOTH, HAND1E47_01, GOBP_POSITIVE_REGULATION_OF_DEVELOPMENTAL_PROCESS, COWLING_MYCN_TARGETS, chr4q21, GOBP_ODONTOGENESIS

GO Biological Process (2): positive regulation of biomineral tissue development (GO:0070169), positive regulation of enamel mineralization (GO:0070175)

GO Molecular Function (1): protein binding (GO:0005515)

GO Cellular Component (1): extracellular region (GO:0005576)

GO top-level categories

Rollup of top GO terms by namespace:

CategoryTerms
biomineral tissue development1
positive regulation of developmental process1
regulation of biomineral tissue development1
enamel mineralization1
positive regulation of tooth mineralization1
regulation of enamel mineralization1
binding1
cellular anatomical structure1

Protein interactions and networks

STRING

250 interactions, top by confidence (×1000):

Protein AProtein BPartner UniProtScore
ODAPHWDR72Q3MJ13813
ODAPHSACK1HQ6ZRV2773
ODAPHENAMQ9NRM1773
ODAPHMMP20O60882728
ODAPHAMBNQ9NP70720
ODAPHAMTNQ6UX39720
ODAPHAMELXQ99217720
ODAPHSLC24A4Q8NFF2696
ODAPHGPR68Q15743683
ODAPHFAM20AQ96MK3665
ODAPHODAMA1E959653
ODAPHKLK4Q9Y5K2637
ODAPHACP4Q9BZG2620
ODAPHMMP25Q9NPA2606
ODAPHLAMB3Q13751602

IntAct

16 interactions, top by confidence:

ABTypeScore
ODAPHMDFIpsi-mi:“MI:0915”(physical association)0.720
ODAPHUBQLN2psi-mi:“MI:0915”(physical association)0.560
LCN2ODAPHpsi-mi:“MI:0915”(physical association)0.560
ODAPHTCAF2psi-mi:“MI:0914”(association)0.530
ODAPHMDFIpsi-mi:“MI:0915”(physical association)0.000
ODAPHUBQLN2psi-mi:“MI:0915”(physical association)0.000
ODAPHLCN2psi-mi:“MI:0915”(physical association)0.000

BioGRID (75): C4orf26 (Two-hybrid), NUDT8 (Affinity Capture-MS), C9orf41 (Affinity Capture-MS), ANKRD50 (Affinity Capture-MS), JMJD4 (Affinity Capture-MS), SLC4A7 (Affinity Capture-MS), FBN1 (Affinity Capture-MS), FAM115C (Affinity Capture-MS), TRPC4AP (Affinity Capture-MS), NPHP3 (Affinity Capture-MS), GPC3 (Affinity Capture-MS), PMPCB (Affinity Capture-MS), PMPCA (Affinity Capture-MS), HAPLN3 (Affinity Capture-MS), TOP3A (Affinity Capture-MS)

ESM2 similar proteins: A0A0G2K6Z9, A0A1D0BN92, A0A411D538, A1YQ92, B3A0Q4, D5L5Q8, H2A0M0, K9N4Q4, O08546, O15946, O35979, O35985, O36359, P06796, P07498, P0DMD3, P0DMD4, P11841, P13432, P15450, P18897, P34468, P54684, P55796, P79139, P81058, P81059, P83055, P83474, P86735, Q01493, Q09283, Q17RF5, Q28441, Q28451, Q28794, Q29135, Q29137, Q61900, Q7T6X1

Diamond homologs: A0A0G2K6Z9, Q17RF5

SIGNOR signaling

0 interactions.

Disease & clinical

Clinical variants and AI predictions

ClinVar

24 variants total. Per-class counts are floors (≥ shown; pagination cap):

ClassificationCount (floor)
Pathogenic3
Likely pathogenic4
Uncertain significance1
Likely benign5
Benign7

Top pathogenic / likely-pathogenic (7)

Variant IDHGVSClassification
37216NM_178497.5(ODAPH):c.229C>T (p.Arg77Ter)Pathogenic
37217NM_178497.5(ODAPH):c.129C>A (p.Cys43Ter)Pathogenic
37218NM_178497.5(ODAPH):c.68-2A>TPathogenic
3357780NM_178497.5(ODAPH):c.68-2A>GLikely pathogenic
37219NM_178497.3(C4orf26):c.318G>ALikely pathogenic
37220NM_178497.5(ODAPH):c.51_56delinsATGCTGGTTACTGGTA (p.Val18fs)Likely pathogenic
4813733NM_178497.5(ODAPH):c.225dup (p.Pro76fs)Likely pathogenic

SpliceAI

273 predictions. Top by Δscore:

VariantEffectΔscore
4:75564109:CACAG:Cacceptor_loss0.9900
4:75564111:CAGGA:Cacceptor_loss0.9900
4:75564112:A:AGacceptor_gain0.9900
4:75564112:AGG:Aacceptor_loss0.9900
4:75564113:G:Aacceptor_loss0.9900
4:75564113:G:GGacceptor_gain0.9900
4:75556148:AG:Adonor_loss0.9700
4:75556149:GG:Gdonor_loss0.9700
4:75556150:GTAAG:Gdonor_loss0.9700
4:75556146:GAAG:Gdonor_gain0.9600
4:75564112:AG:Aacceptor_gain0.9500
4:75564113:GG:Gacceptor_gain0.9500
4:75556133:G:GAdonor_gain0.9200
4:75564113:GGA:Gacceptor_gain0.9200
4:75558106:GCTCT:Gdonor_gain0.9000
4:75564110:A:AGacceptor_gain0.9000
4:75556117:T:Adonor_gain0.8700
4:75556138:C:Gdonor_gain0.8700
4:75564113:GGAC:Gacceptor_gain0.8700
4:75564113:GGACA:Gacceptor_gain0.8700
4:75558150:T:TAdonor_gain0.8600
4:75558151:A:AAdonor_gain0.8600
4:75564112:A:Cacceptor_gain0.8600
4:75564219:TCAC:Tdonor_gain0.8600
4:75558155:ACCT:Adonor_gain0.8500
4:75563208:A:AGacceptor_gain0.8500
4:75563209:G:GGacceptor_gain0.8500
4:75563209:GTA:Gacceptor_gain0.8500
4:75564111:CA:Cacceptor_gain0.8500
4:75556150:G:GGdonor_gain0.8400

AlphaMissense

847 scored. Top likely-pathogenic:

VariantProtein changeam_pathogenicity
4:75564419:A:CS125R0.911
4:75564421:C:AS125R0.911
4:75564421:C:GS125R0.911
4:75564182:T:CF46L0.898
4:75564184:T:AF46L0.898
4:75564184:T:GF46L0.898
4:75564434:A:CS130R0.881
4:75564436:C:AS130R0.881
4:75564436:C:GS130R0.881
4:75564429:A:TE128V0.841
4:75564314:T:CF90L0.813
4:75564316:C:AF90L0.813
4:75564316:C:GF90L0.813
4:75564426:C:TS127F0.808
4:75564175:C:GC43W0.799
4:75564183:T:GF46C0.798
4:75564426:C:AS127Y0.797
4:75556122:T:CC14R0.796
4:75564183:T:CF46S0.784
4:75564180:T:CI45T0.779
4:75556125:T:AW15R0.777
4:75556125:T:CW15R0.777
4:75564173:T:CC43R0.765
4:75564299:T:CF85L0.760
4:75564301:T:AF85L0.760
4:75564301:T:GF85L0.760
4:75564347:T:CF101L0.753
4:75564349:C:AF101L0.753
4:75564349:C:GF101L0.753
4:75564341:T:CF99L0.750

dbSNP variants (sampled 300 via entrez): RS1000094572 (4:75564826 C>T), RS1000288026 (4:75561034 G>A), RS1000490226 (4:75555196 C>T), RS1000519307 (4:75564375 A>G), RS1000530658 (4:75561922 T>A,C,G), RS1000536462 (4:75566340 T>A), RS1000688982 (4:75556358 C>G), RS1000731169 (4:75558840 T>C), RS1000794163 (4:75560166 G>A), RS1000998765 (4:75556025 C>A), RS1001320637 (4:75561084 C>A,T), RS1001410377 (4:75561178 C>G,T), RS1001644152 (4:75565425 T>A,C), RS1001654736 (4:75559199 T>C), RS1001662052 (4:75555608 G>A,C,T)

Disease associations

OMIM: gene MIM:614829 | disease phenotypes: MIM:614832

GenCC curated gene-disease

DiseaseClassificationInheritance
amelogenesis imperfecta hypomaturation type 2A4StrongAutosomal recessive
amelogenesis imperfecta type 2SupportiveAutosomal recessive

Mondo (2): amelogenesis imperfecta hypomaturation type 2A4 (MONDO:0013906), amelogenesis imperfecta type 2 (MONDO:0015048)

Orphanet (1): Amelogenesis imperfecta (Orphanet:88661)

HPO phenotypes

4 total (4 of 4 shown, HPO-id order):

HPOTerm
HP:0000007Autosomal recessive inheritance
HP:0000705Amelogenesis imperfecta
HP:0006285Enamel hypomineralization
HP:0006297Enamel hypoplasia

GWAS associations

2 associations (top):

StudyTraitp-value
GCST001546_4Parkinson’s disease (motor and cognition)5.000000e-06
GCST003160_4Subjective response to lithium treatment in bipolar disorder7.000000e-07

MeSH disease descriptors (1)

DescriptorNameTree numbers
C536606Amelogenesis Imperfecta hypomaturation type (supp.)

Drugs & pharmacology

Drug and pharmacology data

Is drug target: no

PharmGKB: 1 entry (VIP=true, CPIC=false)

CTD chemical–gene interactions

14 total (human), top 14 by PubMed support.

ChemicalActions (top 5)PubMed papers
Estradiolincreases expression, decreases expression, affects cotreatment2
aristolochic acid Iincreases expression1
bisphenol Adecreases expression1
sodium arseniteincreases expression1
2-palmitoylglycerolincreases expression1
(+)-JQ1 compounddecreases expression1
Benzo(a)pyrenedecreases methylation1
Diethylhexyl Phthalateincreases expression1
Diurondecreases expression1
Tobacco Smoke Pollutionincreases expression1
Triclosanincreases expression1
Zearalenonedecreases expression1
beta-Naphthoflavonedecreases expression1
Acrylamideincreases expression1

Clinical trials (associated diseases)

0 trials via MONDO — disease-level, not drug-specific.